Compare, Analyse ALEMBIC PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
ALEMBIC PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs664377-   
Low Rs412272-   
Sales per share (Unadj.) Rs208.7112.1-  
Earnings per share (Unadj.) Rs31.0-28.3-  
Cash flow per share (Unadj.) Rs37.1-23.4-  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.288.0-  
Shares outstanding (eoy) m188.52168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.62.9 89.1%   
Avg P/E ratio x17.4-11.5 -151.2%  
P/CF ratio (eoy) x14.5-13.9 -104.7%  
Price / Book Value ratio x3.73.7 101.2%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46154,766 185.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m7,4673,437 217.2%   
Avg. sales/employee Rs ThNM4,409.0-  
Avg. wages/employee Rs ThNM800.7-  
Avg. net profit/employee Rs ThNM-1,111.0-  
INCOME DATA
Net Sales Rs m39,34718,928 207.9%  
Other income Rs m94133 70.8%   
Total revenues Rs m39,44119,061 206.9%   
Gross profit Rs m8,736-3,280 -266.3%  
Depreciation Rs m1,152817 141.1%   
Interest Rs m184513 35.9%   
Profit before tax Rs m7,493-4,477 -167.4%   
Minority Interest Rs m11-12 -86.5%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568280 560.3%   
Profit after tax Rs m5,844-4,769 -122.5%  
Gross profit margin %22.2-17.3 -128.1%  
Effective tax rate %20.9-6.2 -334.8%   
Net profit margin %14.9-25.2 -58.9%  
BALANCE SHEET DATA
Current assets Rs m19,57713,863 141.2%   
Current liabilities Rs m14,8967,800 191.0%   
Net working cap to sales %11.932.0 37.1%  
Current ratio x1.31.8 73.9%  
Inventory Days Days90111 80.9%  
Debtors Days Days45124 36.6%  
Net fixed assets Rs m27,0978,081 335.3%   
Share capital Rs m37788 429.0%   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,18814,856 183.0%   
Long term debt Rs m4,9935,221 95.6%   
Total assets Rs m47,77828,065 170.2%  
Interest coverage x41.7-7.7 -539.3%   
Debt to equity ratio x0.20.4 52.3%  
Sales to assets ratio x0.80.7 122.1%   
Return on assets %12.6-15.2 -83.2%  
Return on equity %21.5-32.1 -67.0%  
Return on capital %23.6-19.8 -119.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,1201,616 502.6%  
From Investments Rs m-7,556-496 1,523.1%  
From Financial Activity Rs m5904,738 12.5%  
Net Cashflow Rs m1,1535,858 19.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.2 Rs / ZAR

Compare ALEMBIC PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: PFIZER  JUBILANT PHARMOVA   FDC  NATCO PHARMA  SUN PHARMA  



Today's Market

Sensex Trades Marginally Lower, Dow Futures Up by 174 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 29 points, down 0.1% at 48,662 levels.

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALEMBIC PHARMA SHARE PRICE


May 14, 2021 01:36 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS